Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19683486 | 1.00 | ABCB1 (0.31) | ABCB1 | |
| SCHEMBL19683722 | 1.00 | ABCB1 (0.31) | ABCB1 | |
| SCHEMBL19683487 | 1.00 | ABCB1 (0.31) | ABCB1 | |
| SCHEMBL19683673 | 1.00 | ABCB1 (0.31) | ABCB1 | |
| SCHEMBL19683723 | 0.83 | — | — | |
| SCHEMBL19683485 | 0.83 | — | — | |
| SCHEMBL19683490 | 0.83 | — | — | |
| SCHEMBL22547756 | 0.80 | — | — | |
| SCHEMBL19683676 | 0.80 | — | — | |
| SCHEMBL19683674 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10981885-B2 | Tetrahydropyranyl lower alkyl esters and the production of same using a ketene compound | BASF SE | 2021-04-20 | — | — | US | disclosed |
| US-20200325112-A1 | TETRAHYDROPYRANYL LOWER ALKYL ESTERS AND THE PRODUCTION OF SAME USING A KETENE COMPOUND | BASF SE (DE) | 2020-10-15 | — | — | US | disclosed |
| WO-2017207539-A1 | TETRAHYDROPYRANYL LOWER ALKYL ESTERS AND THE PRODUCTION OF SAME USING A KETENE COMPOUND | BASF SE (DE) | 2017-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200325112-A1 | TETRAHYDROPYRANYL LOWER ALKYL ESTERS AND THE PRODUCTION OF SAME USING A KETENE COMPOUND | AKR1B10, CYP51A1, AKR1C4 | ABCB1 2664/4885 |
| US-10981885-B2 | Tetrahydropyranyl lower alkyl esters and the production of same using a ketene compound | AKR1B10, CYP51A1, AKR1C4 | ABCB1 2664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.